Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat in Heart Failure with CKD and Anemia
NCT05691257Phase 4Unknown
- Sponsor
- China-Japan Friendship Hospital
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of roxadustat in anemia (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Change in the hemoglobin from baseline at 8 weeks. Status: unknown.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05691257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05691257.